Neuroendocrine Brake for Type 2 Diabetes Mellitus

Intact Vagal Innervation for and Glucagon-like Peptide-1 (GLP-1) Effects

NCT01176760 ·Status: UNKNOWN ·Phase: NA

A Study of the GI Sleeve for the Treatment of Type 2 Diabetes

NCT02709577 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes Mellitus

NCT03948347 ·Status: UNKNOWN ·Phase: NA

Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 Diabetes

NCT01435980 ·Status: UNKNOWN ·Phase: PHASE4

Vagal Nerve Stimulation and Glucose Metabolism

NCT01117311 ·Status: COMPLETED ·Phase: NA

Investigating the Impact of the SGLT2 Inhibitor Empagliflozin on Postprandial Hypoglycaemia After Gastric Bypass

NCT05057819 ·Status: COMPLETED ·Phase: PHASE4

DSS: Diabetes Surgery Study - Intensive Medical Management of Type 2 Diabetes, With and Without Gastric Bypass Surgery

NCT00641251 ·Status: COMPLETED ·Phase: NA

Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM

NCT05093517 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Effect of Glucagon-like Peptide 2 on Gallbladder Motility After a Meal in Young, Healthy Male Subjects

NCT03682172 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Macrovascular and Microvascular Morbidity and Mortality After Metabolic Surgery Versus Medicines

NCT06355219 ·Status: COMPLETED

Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus

NCT01954147 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Duodenal Exclusion for the Treatment of Type 2 Diabetes

NCT00534547 ·Status: WITHDRAWN ·Phase: NA

Blocking of the Gut Hormone Receptor for Glucagon-like Peptide 2 (GLP-2) by the GLP-2 Receptor Antagonist GLP-2(3-33)

NCT06774807 ·Status: COMPLETED ·Phase: NA

GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow

NCT01988545 ·Status: UNKNOWN ·Phase: NA

GLP-2 (Glucagonlike Peptide-2) and Blood Flow

NCT00540215 ·Status: COMPLETED ·Phase: NA

The Effect of Roux-en-Y Gastric Bypass on Insulin Sensitivity in Type 2 Diabetes

NCT01202526 ·Status: COMPLETED

Insulin Sensitivity and Metabolomics During Oral Administration of Glucose and Graded Intravenous Infusion

NCT03223129 ·Status: COMPLETED ·Phase: NA

Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II Diabetes

NCT05014204 ·Status: COMPLETED ·Phase: NA

The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM)

NCT01449019 ·Status: COMPLETED ·Phase: PHASE1

Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin Secretion

NCT01030952 ·Status: COMPLETED ·Phase: PHASE4

The Role of Pregnancy-induced Gallbladder Dysmotility in the Pathophysiology of Gestational Diabetes Mellitus

NCT04108065 ·Status: COMPLETED

The Role of Metformin and Colesevelam in Human GLP-1 Secretion

NCT02050074 ·Status: COMPLETED ·Phase: PHASE4

The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men

NCT00256256 ·Status: COMPLETED ·Phase: NA

Determinants of Diabetes Remission After Gastric Bypass Surgery

NCT02287285 ·Status: COMPLETED ·Phase: EARLY_PHASE1

The Impact of Glucose Lowering Therapies on Circulating Endothelial Progenitor Cells and Its Mobilising Factor Stromal Derived Factor-1α in Patients With Type 2 Diabetes

NCT02694575 ·Status: COMPLETED